Effectiveness of pacing in tilt-induced vasovagal syncope patients has been studied in 5 multi-center randomized clinical trials [1-5]; 3 non-blinded trials gave positive results and 2 blinded trials gave negative results. Adding together the results of the 5 trials, 318 patients were evaluated; syncope recurred in 21% of the paced patients and in 44% of unpaced patients (p < 0.001). A recent meta-analysis of all studies suggested a non-significant 17% reduction in syncope from the double-blinded studies, and an 84% reduction in the studies where the control group did not receive a pacemaker (PM) [6].All these studies have their limitations. A comparison of these studies causes slight difficulties because of important differences in study design, largely focused on patient selection. Overall, in typical vasovagal population pacing seems to have marginal efficacy. These findings suggest caution in implanting a PM based on the tilt response.Typically, the vasovagal reflex is both hypotensive and cardioinhibitory. The rationale for efficacy of cardiac pacing is that the cardio-inhibitory reflex is dominant in some patients, since there is no role for pacing in preventing vasodilatation and hypotension. While there is a growing skepticism over diagnostic accuracy of tilt testing (TT) for syncope diagnosis, emerging evidence support the use of tilt table testing in assessing susceptibility to reflex hypotension [7]. In this study it is discussed how to decide who can benefit from pacing when vasovagal syncope is present.